DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial
达格列净用于降低心力衰竭合并 2 型糖尿病患者蛋白尿的疗效(DAPPER 研究):一项多中心、随机、开放标签、平行组、标准治疗对照试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102334
Yoshihara, Fumiki; Imazu, Miki; Sakuma, Ichiro; Hiroi, Yukio; Hara, Hisao; Okazaki, Osamu; Ishiguro, Chizuru; Izumi, Chisato; Noguchi, Teruo; Shiraiwa, Toshihiko; Nishioka, Norio; Fujii, Kenshi; Iwakura, Katsuomi; Tomonaga, Osamu; Kobayashi, Koichi; Takihata, Masahiro; Yumoto, Kazuhiko; Takase, Hiroyuki; Himi, Toshiharu; Shimizu, Ikki; Murakami, Tsutomu; Wagatsuma, Kenji; Sato, Katsuhiko; Hiramatsu, Takeyuki; Akabame, Satoshi; Hata, Shiro; Asakura, Masanori; Kawabata, Takanori; Omae, Katsuhiro; Ito, Shin; Kitakaze, Masafumi